Yes, there are several medications specifically used to treat OCD, and they work well for a significant number of people. The first-line options are a class of antidepressants called SSRIs, which increase serotonin activity in the brain. About 46% of people treated with medication experience a meaningful improvement in their symptoms, and additional options exist for those who don’t respond to the first try.
SSRIs: The Primary Medications for OCD
Six SSRIs are commonly prescribed for OCD, all supported by the strongest level of clinical evidence. They are fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications work by keeping more serotonin available in the brain, which helps reduce the intensity of obsessive thoughts and the urge to perform compulsions.
One important distinction: OCD typically requires higher doses than depression does. For example, fluoxetine is often prescribed at 20 mg for depression, but OCD treatment guidelines recommend working up to 60 to 80 mg. Sertraline doses for OCD often reach 150 to 200 mg, compared to the 50 to 100 mg range common for depression. Your prescriber will usually start at a lower dose and increase it over four to six weeks.
There’s strong evidence that these higher doses matter. A meta-analysis of over 2,000 patients found that higher SSRI doses were significantly more effective than medium or low doses at reducing OCD symptoms. The benefit increased steadily up to about 40 mg of fluoxetine (or its equivalent in other SSRIs), after which it leveled off.
How Long OCD Medication Takes to Work
This is where many people get frustrated and give up too early. OCD medications take considerably longer to kick in than the same drugs do for depression. For depression, you might notice improvement in two to four weeks. For OCD, the typical timeline is six to ten weeks before benefits become noticeable. Clinical guidelines recommend sticking with a medication for at least 12 full weeks before concluding it isn’t working. That means reaching an effective dose within the first four to six weeks, then staying on it for another six to eight weeks to give it a fair trial.
What the Side Effects Feel Like
Because OCD often requires higher doses, side effects can be more noticeable than what people experience when taking SSRIs for other conditions. The most common ones include nausea, diarrhea, insomnia, headache, fatigue, and excessive sweating. Sexual dysfunction is particularly common, reported by about 32% of patients in one trial of high-dose escitalopram. Dry mouth affected around 12% in the same study.
Most of these side effects are worst in the first few weeks and tend to ease over time. Sexual side effects, unfortunately, are more persistent and are one of the main reasons people stop taking their medication.
Clomipramine: A Powerful Second Option
Clomipramine (Anafranil) is an older type of antidepressant that actually appears to be more effective for OCD than SSRIs in head-to-head comparisons. Meta-analyses consistently show it produces a larger reduction in symptoms. So why isn’t it prescribed first? Because it comes with a heavier side effect burden: weight gain, dry mouth, constipation, drowsiness, and a risk of heart rhythm changes that SSRIs don’t carry. For this reason, 2025 clinical guidelines list clomipramine as a second-line treatment, recommended when SSRIs haven’t worked well enough.
When the First Medication Doesn’t Work
If an SSRI at an adequate dose for 12 weeks hasn’t helped enough, prescribers have several next steps. One common approach is augmentation, meaning adding a second medication on top of the SSRI rather than replacing it entirely.
Low-dose antipsychotics are the best-studied augmentation option. Aripiprazole (at 5 to 10 mg) and risperidone (at 1 to 3 mg) are both recommended as first-line add-ons. These are especially helpful for people who also have tics. The tradeoff is additional side effects: risperidone augmentation causes sedation in 30 to 35% of people and increased appetite in about 15%, while aripiprazole causes restlessness in over 40%.
A newer area of treatment involves medications that target a different brain chemical called glutamate rather than serotonin. Memantine, originally developed for Alzheimer’s disease, has shown enough promise as an OCD add-on that it’s now listed as a first-line augmentation option in recent guidelines. It’s generally well tolerated. Other glutamate-targeting options include lamotrigine (an anti-seizure medication) and N-acetylcysteine (NAC), an over-the-counter supplement that has shown benefit in controlled studies when added to an SSRI.
OCD Medication for Children and Teens
Fluvoxamine (Luvox) is FDA-approved for treating OCD in children ages 8 and older, based on a 10-week study of 120 young patients. In fact, fluvoxamine’s only approved pediatric use is for OCD. Sertraline is also commonly prescribed for children with OCD. The same general principles apply: doses are started low and increased gradually, and it takes longer to see results than with other conditions. Clomipramine shows even stronger effects in pediatric studies than SSRIs, but the side effect concerns are magnified in younger patients, making it a backup option rather than a starting point.
Medication Combined With Therapy
Both SSRIs and cognitive behavioral therapy (specifically a technique called exposure and response prevention) are considered first-line treatments for OCD, and the best outcomes often come from combining both. One interesting intersection: a compound called D-cycloserine, which acts on glutamate receptors, has been studied as a way to enhance therapy sessions. It doesn’t seem to change the final outcome, but it may speed up the early stages of improvement during exposure therapy.
For people with moderate to severe OCD, starting medication and therapy at the same time is a common approach. Medication can take the edge off symptoms enough to make the hard work of therapy more manageable, while therapy builds skills that last beyond the medication itself.
How Effective OCD Medication Really Is
It helps to have realistic expectations. In clinical studies, about 46% of patients qualify as treatment responders, meaning they experience meaningful, noticeable improvement. “Meaningful improvement” is typically defined as at least a 35% reduction on the standard OCD severity scale. That’s a real, tangible change in daily functioning, not just a statistical blip. But it also means that over half of patients don’t respond adequately to their first medication trial, which is why having multiple options and augmentation strategies matters so much.
Higher doses improve those odds. When comparing high-dose SSRIs to placebo, the number needed to treat is about 4.5, meaning that for roughly every five people started on a high-dose SSRI, one additional person will respond who wouldn’t have on placebo. Those odds improve further when you factor in switching medications, adding augmentation, or combining medication with therapy.